Topical antifungal therapy remains the primary treatment for superficial fungal infections; however, conventional formulations often show limited therapeutic effectiveness due to poor skin penetration, low drug retention, and frequent dosing requirements. Ethosome-based nanocarrier systems have emerged as a promising strategy to enhance transdermal drug delivery due to their unique composition and improved skin permeation capabilities. This review summarizes recent advances in ethosome-based nan